Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ) has issued an announcement.
Extrawell Pharmaceutical Holdings Limited has announced a board meeting scheduled for November 28, 2025, to approve the interim results for the six months ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders and the company’s market positioning.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is known for its commitment to healthcare innovation and serves a diverse market with a range of medical solutions.
Average Trading Volume: 4,212,580
Technical Sentiment Signal: Buy
Current Market Cap: HK$242.2M
Find detailed analytics on 0858 stock on TipRanks’ Stock Analysis page.